GalNAc-L96 intermediate, B1, Purity ≥98%

Synonym: 175724-30-8; Tris[[2-(tert-butoxycarbonyl)ethoxy]methyl]methylamine; Amino-tri-(t-butoxycarbonylethoxymethyl)-methane; Tert-butyl 3,3'-(2-amino-2-((3-tert-butoxy-3-oxopropoxy)methyl)propane-1,3-diyl)bis(oxy)dipropanoate; Di-tert-butyl 3,3'-((2-amino-2-((3-(tert-butoxy)-3-oxopropoxy)methyl)propane-1,3-diyl)bis(oxy))dipropanoate; 3-[2-Amino-3-(2-tert-butoxycarbonyl-ethoxy)-2-(2-tert-butoxycarbonyl-ethoxymethyl)-propoxy]-propionic acid tert-butyl ester

MDL: MFCD18252299
CAS Number: 175724-30-8

Product Size

1 g; 2 g; 5 g; 10 g

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

The triantennary GalNAc ligand GalNAc-L96, which binds ASGPR with high efficiency, facilitates the targeted production of GalNAc-siRNA for improved hepatocyte targeting. B1 can be used for the synthesis of GalNAc-L96 in the creation of GalNAc-RNA conjugates.

Molecular Weight

505.64

Molecular Formula

C₂₅H₄₇NO₉

Form

Solid

Purity

≥98%, determined by HPLC.

Impurities

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.

Identity

Conforms to structure, determined by ¹H NMR.

Test Method

NMR; HPLC